These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 2881446

  • 1. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
    Rondot P, Bathien N.
    Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
    [No Abstract] [Full Text] [Related]

  • 2. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
    [No Abstract] [Full Text] [Related]

  • 3. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V, Melamed E.
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [Abstract] [Full Text] [Related]

  • 4. EMG patterns in abnormal involuntary movements induced by neuroleptics.
    Bathien N, Koutlidis RM, Rondot P.
    J Neurol Neurosurg Psychiatry; 1984 Sep; 47(9):1002-8. PubMed ID: 6148381
    [Abstract] [Full Text] [Related]

  • 5. [Abnormal movements induced by psychotropic drugs].
    Rondot P, Bathien N.
    Encephale; 1979 Sep; 5(1):41-8. PubMed ID: 477589
    [Abstract] [Full Text] [Related]

  • 6. Movement disorders with neuroleptic drug treatment.
    Tarsy D.
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [Abstract] [Full Text] [Related]

  • 7. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
    Metzer WS, Paige SR, Newton JE.
    Mov Disord; 1993 Sep; 8(1):43-6. PubMed ID: 8093548
    [Abstract] [Full Text] [Related]

  • 8. [Physiopathology and curative treatment of tardive dyskinesia].
    Wolf MA, Gautier J.
    Encephale; 1987 Sep; 13(5):301-8. PubMed ID: 2892663
    [Abstract] [Full Text] [Related]

  • 9. Effects of anticholinergic agents on patients with tardive dyskinesia and concomitant drug-induced parkinsonism.
    Wirshing WC, Freidenberg DL, Cummings JL, Bartzokis G.
    J Clin Psychopharmacol; 1989 Dec; 9(6):407-11. PubMed ID: 2574192
    [Abstract] [Full Text] [Related]

  • 10. Tardive dyskinesia. Pathophysiological mechanisms and clinical trials.
    Gerlach J.
    Encephale; 1988 Sep; 14 Spec No():227-32. PubMed ID: 2905651
    [Abstract] [Full Text] [Related]

  • 11. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H, Geraisy N, Schwartz M.
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [Abstract] [Full Text] [Related]

  • 12. Tardive tremor.
    Stacy M, Jankovic J.
    Mov Disord; 1992 Apr; 7(1):53-7. PubMed ID: 1348352
    [Abstract] [Full Text] [Related]

  • 13. [Tardive dyskinesias].
    Mignot G.
    Encephale; 1983 Apr; 9(2):151-66. PubMed ID: 6139271
    [Abstract] [Full Text] [Related]

  • 14. [Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
    Ringwald E.
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Nov; 11(6):294-8. PubMed ID: 33397
    [Abstract] [Full Text] [Related]

  • 15. Clinical activity of GABA agonists in neuroleptic- and L-dopa-induced dyskinesia.
    Morselli PL, Fournier V, Bossi L, Musch B.
    Psychopharmacology Suppl; 1985 Nov; 2():128-36. PubMed ID: 2860656
    [Abstract] [Full Text] [Related]

  • 16. Propranolol for tardive dyskinesia and extrapyramidal side effects (pseudoparkinsonism) from neuroleptics.
    Kulik FA, Wilbur R.
    Psychopharmacol Bull; 1980 Jul; 16(3):18-9. PubMed ID: 6105690
    [No Abstract] [Full Text] [Related]

  • 17. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA, Rexroth K.
    Schizophr Bull; 1980 Jul; 6(1):102-16. PubMed ID: 6102788
    [Abstract] [Full Text] [Related]

  • 18. Tardive dyskinesia: a role for the endogenous opioid system.
    Sandyk R.
    Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic response to progabide in neuroleptic- and L-dopa-induced dyskinesias.
    Ziegler M, Fournier V, Bathien N, Morselli PL, Rondot P.
    Clin Neuropharmacol; 1987 Jun; 10(3):238-46. PubMed ID: 2900682
    [Abstract] [Full Text] [Related]

  • 20. [Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].
    Bathien N, Rondot P, Koutlidis RM.
    J Physiol (Paris); 1981 Apr; 77(1):131-41. PubMed ID: 6112268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.